two us companies have been accused of patent violations by the Council of Scientific and Industrial Research ( csir ), New Delhi. The two companies -- Nature's Herb and New Jersey-based Sabinsa Corporation -- have been allegedly found selling medical formulations developed and patented in us by csir .
'Proclive' -- a herbal drug developed in one of the csir 's laboratories -- is being allegedly sold as a health food by Nature's Herb. In another case of patent violation spotted by csir , Sabinsa Corporation is marketing 'bioprine' similar to 'piprine' that is a formulation for a tuberculosis drug patented by csir in the us and Europe.
csir is preparing to file a case in the us courts, according to H R Bhojwani, head of the business development division in csir . He called it "the ultimate in piracy" and was amazed by the 'audacity' of Nature's Herb in selling 'picrolive' as its own and under the same name given to it by it's Indian developers.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.